Salspera

SSP-20-006
(SALTKIVA)

NCT04589234

JCP089

A Phase 2 Study of Saltikva (Attenuated Salmonella Typhimurium Containing the Human Gene for Interleukin-2) in Patients With Metastatic Pancreatic Cancer

Status:

Recruiting

26459-200.png

II

Phase

Line of Therapy.png

1st

Line of Therapy

Disease Stage.png

Advanced / Metastatic

Disease Stage

Target.png

Biomarker(s)

N/A

Investigational

Product

Saltikva

Attenuated Salmonella Typhimurium containing the gene for human IL-2 (Salmonella-IL2) (p.o.)

Treatment Arms

o Experimental: Saltikva with FOLFIRINOX

o Experimental: Saltikva with Gemcitabine/Abraxane